|
07.01.2010
The German biotechnology industry is keeping calm in the face of the financial crisis. This is underlined by the latest survey of public opinion conducted by Bio Deutschland and the industry magazine |transkript.
|
|
07.01.2010
A German-Spanish research team has fully characterised one of the world’s simplest living creatures. In the search for the fundamentals of life, they have concluded that simple does not necessarily mean simplistic.
|
|
20.10.2009
Efforts to bring meaningful reductions in carbon dioxide emissions must include the contribution of industrial biotechnology. This was the conclusion of a recent study from the environmental group World Wildlife Fund.
|
|
15.10.2009
Biotechnica 2009 was again an important meeting place for the biotech industry, pulling in roughly 11,000 visitors to Hanover. And despite the crisis, the overall mood was positive.
|
|
30.06.2009
For a lot of patients biotechnologically produced drugs are a new hope, for health insurance companies they are a raising cost factor. This is the conclusion of a new study.
|
|
22.05.2009
Despite a sharp decline in visitor numbers, the biotech industry remained optimistic at the largest industry gathering worldwide. The BIO International Convention was held from 18 to 21 May in Atlanta, USA.
|
|
20.04.2009
Biogas could represent an environmentally friendly and renewable source of energy. One of the largest Biogas plants in the world, which will use new technology to supply energy for thousands of households and companies, is currently being constructed in Saxony-Anhalt.
|
|
17.03.2009
In 2006 Jan-Michael Heinrich convinced the jury of GO-Bio with his idea: a very special sieving technique, which isolates biomolecules out of a liquid. Now, the young entrepeneur convinced investors for his Pluriselect GmbH.
|
|
25.02.2009
The German biotech industry has been waiting for such news for a long time, and now it has come. The first antibody made in Germany has cleared its biggest hurdle before market entrance after receiving the green light from the European approval authority, the EMEA.
|
|
11.02.2009
The Boehringer Ingelheim Foundation at the University of Mainz will be donating 100 million euros for an excellence centre for the life sciences. From 2011, it is hoped that the centre will enable Mainz to compete internationally for the best scientific minds.
|
